Myriam Sainz-Ramos is a Ph.D. student at the University of the Basque Country UPV/EHU in the School of Pharmacy. She studied for a Pharmacy degree at the University of the Basque Country UPV/EHU. She then started her Ph.D. studies in the fields of gene therapy and 3D bioprinting, developing non-viral vectors based on cationic lipids for the treatment of genetic diseases such as cystic fibrosis. She is part of the NanoBiocel research group and the Biomedical Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN).
Myriam Sainz-Ramos is a Ph.D. student at the University of the Basque Country UPV/EHU in the School of Pharmacy. She studied for a Pharmacy degree at the University of the Basque Country UPV/EHU. She then started her Ph.D. studies in the fields of gene therapy and 3D bioprinting, developing non-viral vectors based on cationic lipids for the treatment of genetic diseases such as cystic fibrosis. She is part of the NanoBiocel research group and the Biomedical Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN).